INTRODUCTION
Urine from anemic patients and plasma from anemic animals have long served as sources of erythropoietin (Ep), the hormone which specifically regulates erythropoiesis. During the last two decades, simple as well as complex biochemical and biophysical procedures have been employed to purify this glycoprotein. Procedures such as precipitation with ethanol, acetone, tannic acid, and benzoic acid have proven useful in concentrating the hormone. Other techniques such as flash evaporation, ultrafiltration, selective dialysis against drying agents, DEAE-cellulose chromatography, and adsorption and elution from kaolin have also been used [1] [2] [3] .
Purification of erythropoietin has proven to be a major task because of the lability of the purified moiety and insufficient quantities of initial raw material (e.g., urine from anemic patients or plasma from anemic sheep). The purification of Ep has, however, been achieved by Miyake et al. [4] . This material from urines voided by aplastic anemic patients contained 79,000 units of Ep activity per mg of protein with a molecular weight of 39,000 to 40,000. It produced a single band on gel electrophoresis at pH 6 in the presence of 0.05 percent Triton X-100, and yielded a single band on gel electrophoresis at pH 7 in the presence of sodium dodecylsulfate and mercaptoethanol.
Recent reports have described that contaminated preparations of erythropoietin exist and have discussed their possible effects on hematopoiesis [5] . The The cell cultures were incubated at 370 C in a humidified atmosphere flushed with 5 percent CO2 in air. Colonies were stained and identified as erythroid by the improved benzidine staining method of Gallicchio and Murphy [8] and scored using an inverted microscope (Wild, Heerbrugg, Switzerland) at 40x magnification. For higher resolution light microscopy, individual colonies were plucked from the culture plate and cytocentrifuged (Cytospin, Shandon-Elliot, Sewickley, PA) at 500 rpm for five minutes and examined after Wright/Giemsa counter staining.
Step III, MU-3, and M-7 erythropoietin preparations were individually dissolved in alpha medium and then subjected to continuous dialysis (Spectraphor membrane tubing, cylindrical diameter 14.6 mm, MW cutoff 6,000-8,000, Spectrum Medical Industries, Inc., Los Angeles, CA) against alpha medium for 24 hours at 4°C. The dialysis medium (i.e., dialysate) was changed after four hours; the ratio of the dialysate to dialysand was 15:1. Protein determinations before and after analysis were performed using the method of Lowry [9] . Normal murine marrow cells were plated in the presence of varying concentrations of either dialyzed or non-dialyzed erythropoietin (i.e., 0.25 to 2.0 IU per ml). Samples of erythropoietin were assayed for Ep activity in the exhypoxic, polycythemic mouse bioassay of Camiscoli and Gordon [10] .
The erythropoietin preparations were also sterilized by membrane filtration using Nalgene (0.45 ,um pore size, polystyrene nitrocellulose composition, Nalge Corp., Rochester Nalgene filtration or Selas silver filtration as determined by the exhypoxic, polycythemic mouse bioassay (Table 2 ). This in vivo assay was confirmed and extended by the impaired ability of such Millipore sterilized material to induce erythroid colony formation in vitro (Table 3) . DISCUSSION The various contaminants in erythropoietin preparations and the subsequent anomalous effects these moieties may exert on hematopoiesis is of considerable concern. Studies employing Millipore filtration for sterilization of both erythropoietin and colony stimulating activity have reported loss of both factors [11] [12] [13] [14] . We now report that Millipore filtered Ep preparations had a reduced capacity to produce CFU-e derived colonies in culture and also a reduced 59Fe incorporation into red blood cells when measured in the Ep mouse bioassay. Human Ep preparation M-7, treated by whatever means, demonstrated no interference with the development of BFU-e derived bursts. The latter datum is consonate with the proposition that P,FU-e are relatively insensitive to Ep but are dependent on an imperfectly defined factor(s), "burst promoting activity" (BPA) [ 15, 16] . CFU-e, on the other hand, are exquisitely sensitive to, and their viability in vitro is reliant upon, Ep [15] . The loss of Ep following Millipore filtration lends support to both of these contentions and indicates that BPA is not removed by Millipore filtration as is Ep.
The treatment of Ep by membrane dialysis prior to its in vitro use indicates that dialysis of Ep can significantly improve the plating efficiency of both CFU-e and BFU-e at 2 IU Ep (p value < 0.01-0.06). Such membrane dialysis treatment removes small molecules which may be inhibitors present in such Ep preparation. Routine membrane dialysis treatment of Ep prior to employment in murine clonal cell cultures has already been recommended by Ogawa [ 17] . The exact chemical nature of these dialyzable and unwanted moieties remains, however, to be established.
The exact means whereby Millipore filters resulted in a loss of Ep activity is still not clear. It has been suggested that the composition of the filters themselves may Heretofore, all the reported studies which have been performed reflected the inability of Millipore treated Ep preparations to influence 59Fe incorporation in diffusion chambers [12] or 59Fe incorporation into erythrocytes [13] ; however, no documented studies have been reported comparing various filtered preparations using the in vitro clonal erythroid stem cell assay. These present studies suggest that prior treatment of erythropoietin by dialysis followed by either Nalgene or silver filter sterilization reduces contamination by as yet undefined substances without any loss of Ep during filtration. It is suggested that Ep preparations for in vitro clonal stem cell usage be treated in this manner until a supply of pure hormone becomes more readily available.
